News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
33 Results
33 Results
RECOVER’s mid-year milestones: A look at 2025 progress
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Feature
Collaborating to advance Long COVID research: RECOVER researchers team up across the Pacific Northwest
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
Feature
RECOVER Representatives help inform and raise awareness about RECOVER research
Patient, Caregiver, and Community Representatives inform RECOVER research, help connect the initiative with different communities, and share news about RECOVER studies.
Feature
R3 Seminar Recap: Ethical considerations for enrolling “invested parties” in large-scale clinical studies: Insights from the RECOVER Initiative
During the January 28th RECOVER Research Review (R3) Seminar, Dr. Kellie Owens, PhD (NYU Grossman School of Medicine) shared ethical guidance for enrolling individuals in clinical studies who have direct involvement with the research. Dr. Owens was joined by co-authors Leah Castro, MA (RECOVER Community and Caregiver Representative) and Rebecca Letts (RECOVER Patient and Caregiver Representative), who described Representatives’ important role in designing RECOVER clinical studies and developing peer-reviewed research publications.
R3 Seminar Recap
NIH hosts January 10 webinar to discuss RECOVER-TLC’s progress
NIH leaders will provide updates and answer questions about RECOVER’s latest efforts to identify safe and effective treatments for Long COVID.
Announcement
Reviewing RECOVER’s impact in 2024
In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.
Feature
NIH directors highlight RECOVER’s progress and impact
Editorial by NIH leaders shares how RECOVER has worked and will continue working to ease the suffering of those living with Long COVID.
Announcement
NIH adds funds to Long COVID research, advances work on new clinical trials
The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.
News Release